Free IASLC resource that helps pathologists, laboratory scientists, and practicing physicians better understand the background, protocol, and interpretation of results of ALK and ROS1 testing for patients with advance non-small cell lung cancer.
Updated with Chinese and Japanese text translations.
No Details Provided
The developer will be required to provide privacy details when they submit their next app update.
- Editorial Rx Inc.
- 22 MB
Requires iOS 9.0 or later. Compatible with iPhone, iPad and iPod touch.
- Age Rating
- Infrequent/Mild Medical/Treatment Information
- © International Association for the Study of Lung Cancer
Up to six family members will be able to use this app with Family Sharing enabled.